Ads

 

Ads

 

Ads

 

Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of January 2024

Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of Jan-05-2024

  1. Olema Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    10,291
    Market Cap (Jan-05-2024)
    0.733 Billion USD
    World Rank (Jul-30-2023)
    15,099
    Market Cap (Jul-30-2023)
    0.343 Billion USD
    World Rank (Dec-25-2022)
    21,255
    Market Cap (Dec-25-2022)
    0.107 Billion USD
    World Rank (Jan-07-2022)
    16,820
    Market Cap (Jan-07-2022)
    0.29 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -24 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    Company Profile
    Olema Pharmaceuticals is a Clinical Stage Biopharmaceutical company. It is committed to the discovery, development and commercialization of a transformational generation of targeted therapies for women’s cancers. The headquarters is in USA.
  2. PureTech Health plc

    World Rank (Jan-05-2024)
    10,326
    Market Cap (Jan-05-2024)
    0.728 Billion USD
    World Rank (Jul-30-2023)
    9,828
    Market Cap (Jul-30-2023)
    0.812 Billion USD
    World Rank (Dec-25-2022)
    8,847
    Market Cap (Dec-25-2022)
    0.913 Billion USD
    World Rank (Jan-07-2022)
    8,692
    Market Cap (Jan-07-2022)
    1.15 Billion USD
    Annual Revenue in USD
    2 Million USD
    Annual Operating Income in USD
    -197 Million USD
    Annual Net Income in USD
    -50 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    PureTech Health is a Biotechnology company. The headquarters is in USA.
  3. Bicycle Therapeutics

    World Rank (Jan-05-2024)
    10,344
    Market Cap (Jan-05-2024)
    0.725 Billion USD
    World Rank (Jul-30-2023)
    9,329
    Market Cap (Jul-30-2023)
    0.892 Billion USD
    World Rank (Dec-25-2022)
    8,977
    Market Cap (Dec-25-2022)
    0.891 Billion USD
    World Rank (Jan-07-2022)
    7,504
    Market Cap (Jan-07-2022)
    1.48 Billion USD
    Headquarters Country
  4. ALX Oncology Holdings Inc

    World Rank (Jan-05-2024)
    10,415
    Market Cap (Jan-05-2024)
    0.717 Billion USD
    World Rank (Jul-30-2023)
    16,993
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    13,048
    Market Cap (Dec-25-2022)
    0.454 Billion USD
    World Rank (Jan-07-2022)
    10,788
    Market Cap (Jan-07-2022)
    0.78 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -83 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ALX Oncology is a Clinical Stage Biotechnology company working on Immuno Oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. The company annual revenue is approximately 185.7 million USD. The headquarters is in USA.
  5. Calliditas Therapeutics AB

    World Rank (Jan-05-2024)
    10,495
    Market Cap (Jan-05-2024)
    0.707 Billion USD
    World Rank (Jul-30-2023)
    12,880
    Market Cap (Jul-30-2023)
    0.490 Billion USD
    World Rank (Dec-25-2022)
    12,950
    Market Cap (Dec-25-2022)
    0.461 Billion USD
    World Rank (Jan-07-2022)
    12,202
    Market Cap (Jan-07-2022)
    0.61 Billion USD
    Headquarters Country
  6. Vera Therapeutics Inc.

    World Rank (Jan-05-2024)
    10,674
    Market Cap (Jan-05-2024)
    0.689 Billion USD
    World Rank (Jul-30-2023)
    10,207
    Market Cap (Jul-30-2023)
    0.761 Billion USD
    World Rank (Dec-25-2022)
    11,799
    Market Cap (Dec-25-2022)
    0.550 Billion USD
    World Rank (Jan-07-2022)
    14,196
    Market Cap (Jan-07-2022)
    0.45 Billion USD
    Headquarters Country
  7. Travere Therapeutics Inc.

    World Rank (Jan-05-2024)
    10,719
    Market Cap (Jan-05-2024)
    0.683 Billion USD
    World Rank (Jul-30-2023)
    7,507
    Market Cap (Jul-30-2023)
    1.287 Billion USD
    World Rank (Dec-25-2022)
    7,234
    Market Cap (Dec-25-2022)
    1.285 Billion USD
    World Rank (Jan-07-2022)
    6,953
    Market Cap (Jan-07-2022)
    1.70 Billion USD
    Annual Revenue in USD
    212 Million USD
    Annual Operating Income in USD
    -251 Million USD
    Annual Net Income in USD
    -278 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Travere Therapeutics is a biopharmaceutical company whose mission is to identify, develop and deliver life changing therapies to people living with rare disease. The headquarters is in USA.

    Facts About Company

    Travere Therapeutics Annual Total Revenue for year ending Dec-2022 was 212 million USD and and Net loss for year ending Dec-2022 was -278 million USD.

    Travere Therapeutics Annual Total Revenue for year ending Dec-2021 was 227 million USD and and Net loss for year ending Dec-2021 was -180 million USD.

    As on 2022, Travere Therapeutics has 462 employees.

  8. Gracell Biotechnologies Inc.

    World Rank (Jan-05-2024)
    10,757
    Market Cap (Jan-05-2024)
    0.679 Billion USD
    World Rank (Jul-30-2023)
    16,436
    Market Cap (Jul-30-2023)
    0.271 Billion USD
    World Rank (Dec-25-2022)
    19,455
    Market Cap (Dec-25-2022)
    0.153 Billion USD
    World Rank (Jan-07-2022)
    16,212
    Market Cap (Jan-07-2022)
    0.32 Billion USD
    Headquarters Country
  9. Centessa Pharmaceuticals PLC

    World Rank (Jan-05-2024)
    10,928
    Market Cap (Jan-05-2024)
    0.657 Billion USD
    World Rank (Jul-30-2023)
    10,198
    Market Cap (Jul-30-2023)
    0.762 Billion USD
    World Rank (Dec-25-2022)
    15,498
    Market Cap (Dec-25-2022)
    0.310 Billion USD
    World Rank (Jan-07-2022)
    10,634
    Market Cap (Jan-07-2022)
    0.80 Billion USD
    Headquarters Country
  10. Edgewise Therapeutics Inc.

    World Rank (Jan-05-2024)
    11,027
    Market Cap (Jan-05-2024)
    0.646 Billion USD
    World Rank (Jul-30-2023)
    13,494
    Market Cap (Jul-30-2023)
    0.444 Billion USD
    World Rank (Dec-25-2022)
    11,911
    Market Cap (Dec-25-2022)
    0.540 Billion USD
    World Rank (Jan-07-2022)
    10,206
    Market Cap (Jan-07-2022)
    0.87 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -42 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    EDGEWISE THERAPEUTICS, INC. is a biotechnology sector company that creates medicines for rare muscle disorders. Headquarters is in USA.

Share

Ads